Clinical study on radiotherapy combined with xeloda or carboplatin in the treatment of locally advanced esophagus carcinoma
10.3760/cma.j.issn.1008-6706.2012.03.020
- VernacularTitle:放疗联合卡培他滨或顺铂治疗局部晚期食管癌临床研究
- Author:
Hecheng HUANG
;
Lianxing LIN
;
Hesan LUO
;
Shengxi WU
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasms;
Radiotherapy;
Capecitabine;
Cisplatin
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(3):359-361
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effects and toxic side-effects of radiotherapy combined with xeloda or carboplatin respectively for locally advanced esophagus carcinoma.Methods 74 cases with locally advanced esophagus carcinoma were randomly allocated into two groups.One group received radiotherapy combined with Xeloda,500mg at a time,twice a day,taken orally from the beginning of radiotherapy till end of treatment.The second group received radiotherapy combined with Carboplatin by intravenous drip at 100mg a day,for 5 days,from the first week of radiotherapy.Results The overall response rate in the radiotherapy combined with Xeloda group was 91.4％ and 89.7％ in the radiotherapy combined with Carboplatin group.The difference between the two groups was not statistically significant(P ＞0.05 ).Kaplan-Meier survival analysis showed no statistically significant differences in survival between the two groups.The toxic side-effects of gastrointestinal tract,reaction myelosuppression and late radiation reaction were notably alleviated in the Xeloda group compared with the Carboplatin group.Conclusion Compared with Carboplatin,Xeloda combined with radiotherapy had less toxic side-effects for treatment of advanced esophagus carcinoma,with an equal local control rate,which worthy of clinical application.
